Mediclinic International Beheer

Beheer criteriumcontroles 4/4

De CEO Mediclinic International is Ronnie van der Merwe, benoemd in Jun2018, heeft een ambtstermijn van 4.92 jaar. De totale jaarlijkse vergoeding van { bedraagt £ 1.52M, bestaande uit 37.5% salaris en 62.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.009% van de aandelen van het bedrijf, ter waarde £ 332.79K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7 jaar en 4.9 jaar.

Belangrijke informatie

Ronnie van der Merwe

Algemeen directeur

UK£1.5m

Totale compensatie

Percentage CEO-salaris	37.5%
Dienstverband CEO	4.9yrs
Eigendom CEO	0.009%
Management gemiddelde ambtstermijn	7yrs
Gemiddelde ambtstermijn bestuur	4.9yrs

Recente managementupdates

Recent updates

Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today

Jul 26

Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?

Sep 08

Is Mediclinic International (LON:MDC) Using Too Much Debt?

Jun 21

Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?

May 26

If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%

Mar 17

What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?

Feb 26

Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability

Feb 11

Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?

Jan 27

Estimating The Fair Value Of Mediclinic International plc (LON:MDC)

Jan 18

These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively

Jan 01

A Look At Mediclinic International's (LON:MDC) Share Price Returns

Dec 17

Our View On Mediclinic International's (LON:MDC) CEO Pay

Dec 02

Analyse CEO-vergoeding

Hoe is Ronnie van der Merwe's beloning veranderd ten opzichte van Mediclinic International's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2022	n/a	n/a	UK£169m
Jun 30 2022	n/a	n/a	UK£160m
Mar 31 2022	UK£2m	UK£569k	UK£151m
Dec 31 2021	n/a	n/a	UK£135m
Sep 30 2021	n/a	n/a	UK£118m
Jun 30 2021	n/a	n/a	UK£93m
Mar 31 2021	UK£1m	UK£434k	UK£68m
Dec 31 2020	n/a	n/a	-UK£173m
Sep 30 2020	n/a	n/a	-UK£414m
Jun 30 2020	n/a	n/a	-UK£367m
Mar 31 2020	UK£739k	UK£543k	-UK£320m
Dec 31 2019	n/a	n/a	-UK£97m
Sep 30 2019	n/a	n/a	UK£126m
Jun 30 2019	n/a	n/a	-UK£12m
Mar 31 2019	UK£689k	UK£447k	-UK£151m

Compensatie versus markt: De totale vergoeding ($USD 1.88M ) Ronnie } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 3.01M ).

Compensatie versus inkomsten: De vergoeding van Ronnie is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Ronnie van der Merwe (59 yo)

4.9yrs

Tenure

UK£1,519,000

Compensatie

Dr. Carel Aron van der Merwe, also known as Ronnie, has been Executive Director of Mediclinic International plc since June 1, 2018. Dr. van der Merwe serves as Group Chief Executive Officer of Mediclinic I...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Carel van der Merwe	Group CEO & Executive Director	4.9yrs	UK£1.52m	0.0090% £ 332.8k
Petrus Myburgh	Group CFO & Executive Director	6.8yrs	UK£1.00m	0.013% £ 473.5k
Koert H. Pretorius	Group Chief Operating Officer	16.5yrs	UK£339.18k	geen gegevens
Dirk Le Roux	Group Chief Information Officer	8.8yrs	UK£132.90k	geen gegevens
James Arnold	Head of Investor Relations	no data	geen gegevens	geen gegevens
Gert Hattingh	Group Chief Governance Officer	7.3yrs	UK£239.51k	geen gegevens
Biren Valodia	Chief Marketing Officer of Medi-Clinic Southern Africa	no data	geen gegevens	geen gegevens
Clara Findlay	Chief Legal Officer of Medicalinic Southern Africa	no data	geen gegevens	geen gegevens
Wimpie Aucamp	Chief Operating Officer of Medi-Clinic for Southern Africa	no data	geen gegevens	geen gegevens
Daniel Liedtke	Chief Executive Officer of Hirslanden	4.3yrs	geen gegevens	geen gegevens
Greg Wyk	CEO & Chief Human Resources Officer of Medicalinic Southern Africa	no data	geen gegevens	geen gegevens
Raymond Plotz	Chief Information Officer of Medicalinic Southern Africa	no data	geen gegevens	geen gegevens

7.0yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van MDC is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Carel van der Merwe	Group CEO & Executive Director	4.9yrs	UK£1.52m	0.0090% £ 332.8k
Petrus Myburgh	Group CFO & Executive Director	6.8yrs	UK£1.00m	0.013% £ 473.5k
Thomas Singer	Independent Non-Executive Director	3.8yrs	UK£90.00	0.0027% £ 100.1k
Daniel Meintjes	Non-Executive Director	27.3yrs	UK£74.00	0.017% £ 620.9k
Jan Durand	Non-Executive Director	11.3yrs	UK£80.00	geen gegevens
Muhadditha Al-Hashimi	Independent Non-Executive Director	5.5yrs	UK£77.00	geen gegevens
Inga Beale	Independent Non-Executive Chairman	3.2yrs	UK£280.00	geen gegevens
Zarina Bibi Bassa	Independent Non-Executive Director	1.3yrs	UK£12.00	geen gegevens
Felicity A. Harvey	Senior Independent Director	5.6yrs	UK£92.00	geen gegevens
Steve Weiner	Independent Non-Executive Director	2.8yrs	UK£94.00	geen gegevens
Anja Oswald	Independent Non-Executive Director	4.8yrs	UK£78.00	geen gegevens
Natalia Barsegiyan	Independent Non-Executive Director	1.8yrs	UK£53.00	geen gegevens

4.9yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MDC wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.9 jaar).

Mediclinic International Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Independent Non-Executive Director recently bought UK£73k worth of stock

High number of new directors

High number of new directors

High number of new directors

High number of new directors

High number of new directors

Recent updates

Financial Conduct Authority Cancels the Listing of Mediclinic Shares on the London Stock Exchange and Delisting of Shares from the JSE and the NSX Expects to Take Effect on 7 June 2023

Mediclinic International's Cancellation of Shares from Official List and Main Market of LSE Expected to Take on 30 May 2023; Delisting of Shares from JSE and NSX Expected to Take Effect from Commencement of Trade on 7 June 2023

Mediclinic International plc(LSE:MDC) dropped from FTSE 350 (Ex Investment Companies) Index (GBP)

Cancellation of Listing of Mediclinic Shares on the LSE Is Expected on 26 May 2023

Mediclinic International plc (LSE:MDC) acquired Artisan Biomed.

Mediclinic International plc Approves Final Cash Dividend, Payable on 26 August 2022

Mediclinic International plc to Delist

Mediclinic International plc Approves Final Cash Dividend

Upcoming dividend of UK£0.03 per share

Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today

Estimating The Intrinsic Value Of Mediclinic International plc (LON:MDC)

Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly

Remgro Wants Equal Partner in Possible Mediclinic Buyout

Price target increased to UK£4.26

Price target increased to UK£4.09

Mediclinic International Ordinary Shares to Be Deleted from OTC Equity

Independent Non-Executive Director recently bought UK£73k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Mediclinic International plc to Report First Half, 2023 Results on Nov 16, 2022

High number of new directors

Mediclinic International plc to Report Fiscal Year 2022 Results on May 25, 2022

Are Investors Undervaluing Mediclinic International plc (LON:MDC) By 50%?

High number of new directors

Is Mediclinic International (LON:MDC) Using Too Much Debt?

High number of new directors

Mediclinic International (LON:MDC) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings released: EPS UK£0.088 (vs UK£0.02 in 1H 2021)

High number of new directors

High number of new directors

Senior Independent Director J. Grieve has left the company

Independent Non-Executive Director Trevor Petersen has left the company

Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.43 loss in FY 2020)

Is Mediclinic International (LON:MDC) Using Too Much Debt?

Consensus forecasts updated

Mediclinic International plc Provides Revenue Guidance for Fiscal 2022

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.43 loss in FY 2020)

Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?

If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%

New 90-day high: UK£3.06

What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?

Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability

Non-Executive Director recently sold UK£52k worth of stock

Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?

Estimating The Fair Value Of Mediclinic International plc (LON:MDC)

These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively

A Look At Mediclinic International's (LON:MDC) Share Price Returns

Our View On Mediclinic International's (LON:MDC) CEO Pay

First half 2021 earnings released: EPS UK£0.02

Revenue beats expectations, earnings disappoint

New 90-day high: UK£3.19

New 90-day high: UK£2.95

New 90-day low - UK£2.46

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd